跳至主要内容
临床试验/NCT04379362
NCT04379362Unknown2 期

Magnetic Resonance Imaging-guided Focal Laser Ablation of Prostate Cancer

Radboud University Medical Center2 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2018年12月14日最近更新:
适应症

试验速览

阶段
2 期
入组人数
53
试验地点
2
主要终点
Urine incontinence incontinence

研究概览

简要总结

Magnetic resonance imaging-guided focal laser ablation of prostate cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 76 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Urine incontinence incontinence

时间窗: At inclusion, 3 months, 6 months, 12 months and 24 months follow up.

To evaluate a change in the functional outcome urine incontinence before and after FLA in patients with localized low to intermediate risk prostate cancer (Gleason 3+3, 3+4 or Gleason 4+3).

次要结局

  • Sexual Health Inventory for Men- International Index of Erectile Function (SHIM-IIEF)(At inclusion, 3 months, 6 months, 12 months and 24 months follow up.)
  • Complication rate(At inclusion , 3 months, 6 months, 12 months and 24 months follow up.)
  • International Consultation on Incontinence Questionnaire (ICIQ)(At inclusion, 3 months, 6 months, 12 months and 24 months follow up.)
  • Quality of life using a validated quality of life questionnaire (EORTC QLQ PR25(At inclusion , 3 months, 6 months, 12 months and 24 months follow up.)
  • Local cancer control(At inclusion , 3 months, 6 months, 12 months and 24 months follow up.)
  • International Prostate Symptom Score (IPSS)(At inclusion, 3 months, 6 months, 12 months and 24 months follow up.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验